Drug-drug interactions associated with kinase inhibitors: highlighting a new resource for oncologists and clinical pharmacists

Ann Oncol. 2016 Apr;27(4):752. doi: 10.1093/annonc/mdw019. Epub 2016 Jan 19.

Authors

H Gelderblom¹, C H Köhne², V Launay-Vacher³, R W F van Leeuwen⁴

Affiliations

¹ Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands [email protected].
² Department of Hematology and Oncology, Klinikum Oldenburg, Oldenburg, Germany.
³ Pitié-Salpêtrière University Hospital, Paris, France.
⁴ Service ICAR, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.

PMID: 26787233
DOI: 10.1093/annonc/mdw019

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Drug Interactions*
Humans
Internet
Neoplasms / drug therapy*
Neoplasms / pathology
Protein Kinase Inhibitors / adverse effects
Protein Kinase Inhibitors / therapeutic use*

Substances

Protein Kinase Inhibitors